SXLV:SW:SW-SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 44.09

Change

0.00 (0.00)%

Market Cap

N/A

Volume

223.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHSRIA:SW UBS ETF (CH) MSCI Switzerland ..

+0.05 (+0.25%)

USD 492,935.36B
XLDX:SW Xtrackers LevDAX Daily Swap UC..

+2.24 (+1.34%)

USD 411,075.38B
CHSRI:SW UBS ETF (CH) - MSCI Switzerlan..

+0.13 (+0.71%)

USD 368,190.74B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

+1.60 (+0.64%)

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.06 (+0.26%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.04 (+0.13%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+1.50 (+0.03%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-3.40 (-0.23%)

USD 134,034.86B

ETFs Containing SXLV:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.22% 48% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.22% 47% F 50% F
Trailing 12 Months  
Capital Gain 11.55% 58% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.55% 58% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.46% 58% F 58% F
Dividend Return 3.46% 58% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.60% 55% F 60% D-
Risk Adjusted Return 61.72% 61% D- 64% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike